Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Kartesia on all Swiss tax, financing and corporate aspects of the transaction. Kartesia, a leading European provider of financing solutions for small...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised Volumina Medical in this financing round. Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Unilabs on the deal. Unilabs, a leading international provider of diagnostic services, has acquired ADUS Radiologie, an esteemed radiology company with three...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing...
You must be a Standard 1 Year member to access this content.
Travers Smith LLP and Walder Wyss advised Inflexion on the deal. Lenz & Staehelin advised Gyrus Capital in this transaction. Inflexion and Gyrus Capital have announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Unilabs in this transaction. Unilabs, a leading diagnostic services provider, has announced it entered into a definitive agreement to acquire Proxilis SA,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Octium Group in this transaction. Octium Group, a leading provider of PPLI solutions, has agreed to acquire Insurevolution’s PPLI business of approximately...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Unilabs in this transaction. Wenger Vieli advised the shareholders of RIMED. Unilabs, a leading diagnostic services provider, and RIMED, a leading Swiss...
You must be a Standard 1 Year member to access this content.
Homburger advised StoneX in this transaction. Lenz & Staehelin advised CDI’s sole shareholder and seller. StoneX Group Inc. (NASDAQ: SNEX), a global financial services company, announced...
You must be a Standard 1 Year member to access this content.
Homburger, Davis Polk and Chiomenti advised Dufry on the deal, while Lenz & Staehelin and BonelliErede assisted Edizione. Gianni & Origoni and PwC TLS advised Autogrill...
You must be a Standard 1 Year member to access this content.
